Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (51-60 of 715) with videos related to

Pageof 72
Sort By:
Current Topics in Microbiology and Immunology|January 20, 1999
Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular developmentP Carmeliet, D Collen
Thrombosis Research|January 1, 1979
alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapyD Collen, M Verstraete
Biochimica Et Biophysica Acta|October 13, 1977
The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsinJ Edy, D Collen
Current Opinion in Lipidology|April 1, 1997
Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosisP Carmeliet, D Collen
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 1994
Oxidized lipoproteins in atherosclerosis and thrombosisP Holvoet, D Collen
Angiologica|January 1, 1970
Dissecting aneurysm of the descending aorta: a frequently unrecognized condition with overrated fatalityM Verstraete, D Collen
Current Opinion in Lipidology|October 23, 1997
Thrombosis and atherosclerosisP Holvoet, D Collen
Lancet (London, England)|December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agentsD Collen, B Sobel
Thrombosis Research|June 1, 1976
Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasmaU Hender, D Collen
Blood|February 1, 1979
Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasmaD Collen, B Wiman
Pageof 72

Showing results (51-60 of 715) with videos related to

Sort By:
Pageof 72
Current Topics in Microbiology and Immunology|January 20, 1999
Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular developmentP Carmeliet, D Collen
Thrombosis Research|January 1, 1979
alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapyD Collen, M Verstraete
Biochimica Et Biophysica Acta|October 13, 1977
The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsinJ Edy, D Collen
Current Opinion in Lipidology|April 1, 1997
Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosisP Carmeliet, D Collen
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 1994
Oxidized lipoproteins in atherosclerosis and thrombosisP Holvoet, D Collen
Angiologica|January 1, 1970
Dissecting aneurysm of the descending aorta: a frequently unrecognized condition with overrated fatalityM Verstraete, D Collen
Current Opinion in Lipidology|October 23, 1997
Thrombosis and atherosclerosisP Holvoet, D Collen
Lancet (London, England)|December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agentsD Collen, B Sobel
Thrombosis Research|June 1, 1976
Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasmaU Hender, D Collen
Blood|February 1, 1979
Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasmaD Collen, B Wiman
Pageof 72